CClinicalTrials.gg
CompletedNCT06621537Updated Nov 8, 2024

Mental Health Burden and Help-seeking Behavior in the Austrian General Population

An observational study in Screening, sponsored by Sigmund Freud PrivatUniversitat. Completed at 1 site in Austria. Open to participants aged 14 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-11-08.

Sponsored by Sigmund Freud PrivatUniversitat · Observational

Study type
Observational
Model
Ecologic or community
Time perspective
Prospective
Enrollment
2,025
Ages
14 Years and older
Sex
All
01

Study summary

This study investigates the symptom burden and help-seeking behavior in the Austrian general population. Current research shows that mental health in Austria has significantly worsened since the COVID-19 pandemic. Lockdowns, social isolation, and uncertainty about the future have led to increased psychological stress, which has remained elevated even after restrictions were lifted. Vulnerable groups such as young people and individuals with a migration background were particularly affected, often experiencing additional stressors like language barriers, cultural differences, and financial strain. Migrant families frequently face more barriers to accessing mental health services, such as linguistic obstacles, lack of knowledge about the healthcare system, insufficient financial resources, stigmatization of mental illness, and cultural differences in understanding mental health. Research shows that migrants are less likely to seek professional help, instead relying on informal networks or alternative healing methods, leaving many untreated.

Therefore, this study aims to further explore these barriers and the differences in help-seeking behavior between individuals with and without migration backgrounds. A representative sample of the Austrian general population will complete validated questionnaires to assess symptom burden, help-seeking behavior, and self-stigmatization. The study findings will help identify obstacles to accessing psychotherapeutic care and provide insight into improving mental health services, particularly for vulnerable groups.

Read the detailed description

The research project focuses on the mental health and help-seeking behaviors of the Austrian general population, with a particular interest in vulnerable groups like individuals with migration backgrounds.

The study employs a comprehensive approach by using an online survey targeting a representative sample of the Austrian general population. Key areas of focus include the symptom burden related to psychological disorders and help-seeking behaviors. The survey incorporates a range of standardised validated measurement tools, including: CORE-OM (to assess psychological well-being, symptoms, functionality, and risks), GHSQ (to evaluate help-seeking behavior), SSOSH (to measure self-stigmatization), PHQ-9 (to assess depressive symptoms), GAD-7 (to measure generalized anxiety disorder), ISI-7 (for insomnia severity), PSS-4 (for stress), CAGE (for alcohol misuse), SOEP (for loneliness), and open questions on stressors and resources.

This study will provide insights into the mental health challenges faced by the general population and identify specific barriers to accessing psychotherapeutic care among people with migration backgrounds. These findings will inform future interventions and support mechanisms for these groups. The recruitment process will involve a professional survey agency (Marketagent GmbH), which will ensure a representative sample, including participants aged 14 and above. Participants must have adequate German language skills and reside in Austria. The results will contribute to improving mental health services and addressing disparities in care access.

02

Conditions studied

  • Screening

Keywords

  • general population
  • Austria
  • help-seeking behavior
  • symptom burden
03

In context

Lead sponsor

Sigmund Freud PrivatUniversitat is the lead sponsor of 12 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
14 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

representative sample of the Austrian general population according to age, gender, age x gender, region and education level

Inclusion criteria

  • at least 14 years old
  • Internet access
  • sufficient German skills
  • residence in Austria

Exclusion criteria

Exclusion Criteria:

  • younger than 14 years old
  • no access to the Internet
  • lack of German language skills
  • residence outside Austria
05

Study design

Observational model
Ecologic or community
Time perspective
Prospective
Enrollment
2,025 participants (actual)
Patient registry
No

Groups and cohorts

  • Representative Sample of the Austrian General Population

    Sample of the Austriang General Population aged \>=14 years representative for age, gender, age x gender, region, education

06

What researchers measure

Primary outcomes

  1. General Help Seeking Behavior

    The General Help-Seeking Questionnaire (GHSQ) is a valdiated standardized tool to assess current intentions to seek help from different sources for different problems. The total score ranges from 10 to 70, with higher scores indicating a greater intention to seek help.

    Time frame: Once in October 2024

  2. Clincial Outcomes in Routine Evaluation

    The Clinical Outcomes in Routine Evaluation - Outcome Measure (CORE-OM) is a common self-report measure of global distress with 34 items all answered on the same five level Likert-type scale asking about the respondents state over the last week. It was originally designed and developed in response to a research funding call from the UK Mental Health Foundation which required that the content must cover domains of well-being (4 items), problems (12 items), functioning (12 items) and risk (6 items). The total score ranges from 0 to 136 (sum of items), with higher scores indicating greater symptom/distress burden. Domain scores range from 0 to 16 (well-being), 0 to 48 (problems and functioning) and 0 to 24 (risk). In addition, means can be calculated by dividing the sum of the items by the number of items in the total score or in the respective domains.

    Time frame: Once in October 2024

Secondary outcomes

  1. Alcohol Abuse

    Symptoms of alcohol abuse will be assessed with a brief screening tool, the so-called CAGE questionnaire. The acronym stands for 4 yes/no items constituting the screening test: 1. Have you ever felt that you ought to Cut down on your drinking? 2. Have people Annoyed you by criticizing your drinking? 3. Have you ever felt bad or Guilty about your drinking? 4. Have you ever had a drink first thing in the morn ing to steady your nerves or to get rid of a hangover (Eye-opener)? The total score ranges from 0 to 4, with higher scores indicating a greater degree of problem drinking behaviour.

    Time frame: Once in October 2024

  2. Insomnia Symptoms

    Symptoms of sleeping disorders will be assessed with the brief version of the insomnia severity index (ISI-7). The total score ranges from 0 to 28, with higher scores indicating higher levels of sleep problems.

    Time frame: Once in October 2024

  3. Depressive Symptoms

    Symptoms of depression will be assessed with the 9 item version of the Patient Health Questionnaire (PHQ-9). The total score ranges from 0 to 27, with higher scores indicating greater symptom burden.

    Time frame: Once in October 2024

  4. Symptoms of Anxiety

    Symptoms of anxiety will be assessed with the 7 item version of the general anxiety disorder scale (GAD-7). The total score ranges from 0 to 21, with higher scores indicating greater symptom burden.

    Time frame: Once in October 2024

  5. Self-stigma

    The construct of self-stigma as an important factor in people\'s decisions not to seek (psycho)therapeutic treatment is assessed using the 10-item Self-Stigma of Seeking Help (SSOSH) scale. The total score ranges from 10 to 50, with higher scores indicating higher levels of self-stigma.

    Time frame: Once in October 2024

  6. Free text questions on resources and burdens

    Two free text questions will elaborate on perceived burdens and resources following a previous study in the Austrian general population. 1. What is currently bothering you the most? 2. What helps you most to cope with your problems at the moment?

    Time frame: Once in October 2024

  7. Perceived Stress Level

    The perceived stress level will be assessed with the short version of the perceived stress scale comprising 4 items (PSS-4). The total score ranges from 0 to 16, with higher scores indicating greater symptom burden.

    Time frame: Once in October 2024

  8. Loneliness

    Perceived social isolation is assessed using the three-item loneliness scale (SOEP). The total score ranges from 0 to 12, with higher scores indicating greater social isolation.

    Time frame: Once in October 2024

07

Study locations

1 site
  • Sigmund Freud Univeristy Vienna
    Vienna, 1020, Austria
08

References and documents

Publications

  • Wilson, C. J., Deane, F. P., Ciarrochi, J., and Rickwood, D. (2005). Measuring Help-Seeking Intentions: Properties of the General Help-Seeking Questionnaire. Canadian Journal of Counselling, 39(1), 15-28.
  • Vogel, D. L., Wade, N. G., and Haake, S. (2006). Measuring the self-stigma associated with seeking psychological help. Journal of Counseling Psychology, 53(3), 325-337. https://doi.org/10.1037/0022-0167.53.3.325
  • Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092-7. doi: 10.1001/archinte.166.10.1092. PubMed 16717171 ↗
  • Schaffler Y, Gachter A, Dale R, Jesser A, Probst T, Pieh C. Concerns and Support after One Year of COVID-19 in Austria: A Qualitative Study Using Content Analysis with 1505 Participants. Int J Environ Res Public Health. 2021 Aug 3;18(15):8218. doi: 10.3390/ijerph18158218. PubMed 34360512 ↗
  • Reinwarth AC, Ernst M, Krakau L, Brahler E, Beutel ME. Screening for loneliness in representative population samples: Validation of a single-item measure. PLoS One. 2023 Mar 16;18(3):e0279701. doi: 10.1371/journal.pone.0279701. eCollection 2023. PubMed 36928277 ↗
  • Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x. PubMed 11556941 ↗
  • Kraepelien M, Blom K, Forsell E, Hentati Isacsson N, Bjurner P, Morin CM, Jernelov S, Kaldo V. A very brief self-report scale for measuring insomnia severity using two items from the Insomnia Severity Index - development and validation in a clinical population. Sleep Med. 2021 May;81:365-374. doi: 10.1016/j.sleep.2021.03.003. Epub 2021 Mar 16. PubMed 33813233 ↗
  • Evans C, Connell J, Barkham M, Margison F, McGrath G, Mellor-Clark J, Audin K. Towards a standardised brief outcome measure: psychometric properties and utility of the CORE-OM. Br J Psychiatry. 2002 Jan;180:51-60. doi: 10.1192/bjp.180.1.51. PubMed 11772852 ↗
  • Dhalla S, Kopec JA. The CAGE questionnaire for alcohol misuse: a review of reliability and validity studies. Clin Invest Med. 2007;30(1):33-41. doi: 10.25011/cim.v30i1.447. PubMed 17716538 ↗
  • Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983 Dec;24(4):385-96. No abstract available. PubMed 6668417 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 8, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06621537
Lead sponsor
Sigmund Freud PrivatUniversitat
Collaborators
Danube University Krems
Responsible party
Sponsor
First posted
Oct 1, 2024
Start date
Oct 10, 2024
Primary completion
Oct 28, 2024
Completion
Oct 28, 2024
Last update
Nov 8, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion